CGNX vs CLOV · P/E 76, rev $914.5M vs rev $1.37B
Cognex Corporation (CGNX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Cognex Corporation (CGNX) is a scientific & technical instruments company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported CGNX revenue for 2024-12-31 was $914.5M. Net income was $106.2M. Revenue was up 9.2% from 2023-12-31 to 2024-12-31. CGNX currently screens at market cap $10.78B and trailing P/E 76.2.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
CGNX currently screens at market cap $10.78B and trailing P/E 76.2. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the CGNX and CLOV stock pages for the full models.
Not investment advice.